Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.77%
1,097.81
-8.55
-0.77%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.29%
612.03
+1.74
+0.29%
—610.29610.29616.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.76%
1,220.43
+9.21
+0.76%
—1,211.221,211.011,222.361,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.50%
1,759.52
+8.81
+0.50%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.54%
631.54
+3.37
+0.54%
—628.17629.38634.09629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.30%
857.16
+2.59
+0.30%
—854.57855.71860.09855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.67%
215.41
-1.46
-0.67%
—216.87216.87217.79215.29——
SIXT
Technology
SIXT
Technology
SIXT
+1.47%
3,614.15
+52.21
+1.47%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.55%
908.30
+4.99
+0.55%
—903.31903.26908.38901.18——
SIXV
Health care
SIXV
Health care
SIXV
-0.08%
1,480.40
-1.14
-0.08%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.07%
2,398.37
-1.58
-0.07%
—2,399.952,404.452,418.812,396.04——
RPGLIFE:NSE
RPG Life Sciences Ltd
₹2,277.20
-3.03%
(-71.20) 1D
May 15, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
₹2,348.00
High
₹2,385.00
Low
₹2,270.10
Mkt. cap
37.66B
Avg. vol.
78.30K
Volume
6.20K
P/E ratio
32.70
52-wk high
₹2,725.00
52-wk low
₹1,733.00
EPS
₹69.64
Shares outstanding
16.54M
No. of employees
1K
News stories
From sources across the web
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1.33K
Founded1993
Headquarters-
SectorPharmaceutical industry
Websiterpglifesciences.com
Last report
Apr 30, 2026
Fiscal Period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.77B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.69B
1.82B
1.80B
1.77B
Cost of goods sold
600.20M
665.80M
649.00M
605.90M
Cost of revenue
600.20M
665.80M
649.00M
605.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
337.00M
361.60M
353.20M
363.00M
Operating expense
785.70M
812.90M
807.50M
892.10M
Total operating expenses
1.39B
1.48B
1.46B
1.50B
Operating income
303.30M
338.10M
343.80M
270.90M
Other non operating income
52.30M
45.40M
34.10M
44.90M
EBT including unusual items
354.30M
494.50M
291.20M
402.00M
EBT excluding unusual items
354.30M
382.30M
375.40M
311.90M
Income tax expense
91.40M
126.00M
69.90M
103.00M
Effective tax rate
25.80%
25.48%
24.00%
25.62%
Other operating expenses
397.30M
399.10M
400.50M
471.70M
Net income
262.90M
368.50M
221.30M
299.00M
Net profit margin
15.56%
20.28%
12.29%
16.90%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.30M
-1.20M
-2.50M
-3.90M
Net interest expenses
-1.30M
-1.20M
-2.50M
-3.90M
Depreciation and amortization charges
51.40M
52.20M
53.80M
57.40M
EBITDA
355.25M
389.90M
395.75M
324.60M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer